Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tomokazu Odoriba"'
Autor:
Akira Terabe, Chiyuki Tanaka, Susumu Okabe, Shozo Muranishi, Takuya Fujita, Tomokazu Odoriba, Hideyuki Tozaki, Tsutomu Suzuki, Akira Yamamoto
Publikováno v:
Life Sciences. 64:1155-1162
The objective of this study was to estimate the therapeutic effects of R68070, a new thromboxane synthase inhibitor, on 2,4,6-trinitrobenzenesulfonic acid sodium salt (TNBS)-induced ulcerative colitis in rats. We also examined the acceleration of the
Autor:
Toshio Taniguchi, Shozo Muranishi, Masahiro Murakami, Akira Yamamoto, Hideyuki Tozaki, Tomokazu Odoriba, Tomoya Iseki, Takuya Fujita
Publikováno v:
Journal of Pharmacy and Pharmacology. 50:913-920
The objective of this study was to examine the effects of protease inhibitors on the absorption of calcitonin from different regions of the intestine in rats. The absorption experiments were investigated by in-situ use of closed intestinal loops in r
Autor:
Shozo Muranishi, Takuya Fujita, Naoki Okada, Hideyuki Tozaki, Akira Yamamoto, Tsutomu Suzuki, Akira Terabe, Tomokazu Odoriba, Susumu Okabe
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 82(1)
The objective of this study was to achieve the colon-specific delivery of an anti-ulcerative colitis drug using chitosan capsules and to accelerate healing of 2,4,6-trinitrobenzene sulfonic acid sodium salt (TNBS)-induced colitis in rats. 5-Aminosali
Autor:
Akira Yamamoto, Takuya Fujita, Akira Terabe, Susumu Okabe, Hideyuki Tozaki, Tomokazu Odoriba, Shozo Muranishi
Publikováno v:
The Journal of pharmacy and pharmacology. 51(10)
A pharmacokinetic model of colon-specific drug delivery developed in a previous study has been validated by use of 5-aminosalicylic acid (5-ASA) as a model anti-inflammatory drug. The simulation curves obtained from the pharmacokinetic model were in